Epidemiology of Kidney Cancer

Overview

Journal Adv Urol

Publisher Wiley

Specialty Urology

Date 2008 Nov 15

PMID 19009036

Citations 29

Authors

D Pascual

A Borque

Affiliations

Soon will be listed here.

Abstract

Some tumors are known to have a definite cause-effect etiology, but renal cell carcinoma (RCC) is not one of them precisely. With regard to RCC we can only try to identify some clinical and occupational factors as well as substances related to tumorigenesis. Smoking, chemical carcinogens like asbestos or organic solvents are some of these factors that increase the risk of the RCC. Viral infections and radiation therapy have also been described as risk factors. Some drugs can increase the incidence of RCC as well as other neoplasms. Of course, genetics plays an outstanding role in the development of some cases of kidney cancer. Chronic renal failure, hypertension, and dialysis need to be considered as special situations. Diet, obesity, lifestyle, and habits can also increase the risk of RCC. The aim of this review is to summarize the well-defined causes of renal cell carcinoma.

Citing Articles

Fat transformation of the tissue of the single left kidney 10 years after treatment of renal cell carcinoma of both kidneys.

Zhumagulova A, Arypzhanov D Rep Pract Oncol Radiother. 2022; 27(2):381-386.

PMID: 36299391 PMC: 9591041. DOI: 10.5603/RPOR.a2022.0018.

Metastatic renal cell carcinoma presenting as subcutaneous nodule.

Haque K, McNew M, Flowers A, Bhargava P, Sangster G, Chu Q Radiol Case Rep. 2022; 17(6):1973-1976.

PMID: 35432677 PMC: 9010887. DOI: 10.1016/j.radcr.2022.03.055.

The incidence of kidney cancer in Iran: a systematic review and meta-analysis.

Hassanipour S, Namvar G, Fathalipour M, Salehiniya H Biomedicine (Taipei). 2018; 8(2):9.

PMID: 29806587 PMC: 5992926. DOI: 10.1051/bmdcn/2018080209.

Epidemiology of renal cancer in developing countries: Review of the literature.

Medina-Rico M, Ramos H, Lobo M, Romo J, Prada J Can Urol Assoc J. 2017; 12(3):E154-E162.

PMID: 29283089 PMC: 5869042. DOI: 10.5489/cuaj.4464.

Copy number variations and expression of MPDZ are prognostic biomarkers for clear cell renal cell carcinoma.

Huang Y, Liu W, Han F, Yang J, Hao X, Chen H Oncotarget. 2017; 8(45):78713-78725.

PMID: 29108259 PMC: 5667992. DOI: 10.18632/oncotarget.20220.

References

Maxwell P, Wiesener M, Chang G, Clifford S, Vaux E, Cockman M . The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999; 399(6733):271-5. DOI: 10.1038/20459. View

Hunt J, van der Hel O, McMillan G, Boffetta P, Brennan P . Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies. Int J Cancer. 2004; 114(1):101-8. DOI: 10.1002/ijc.20618. View

BRENNAN J, Stilmant M, Babayan R, Siroky M . Acquired renal cystic disease: implications for the urologist. Br J Urol. 1991; 67(4):342-8. DOI: 10.1111/j.1464-410x.1991.tb15158.x. View

Baynham S, Katner H, Cleveland K . Increased prevalence of renal cell carcinoma in patients with HIV infection. AIDS Patient Care STDS. 1997; 11(3):161-5. DOI: 10.1089/apc.1997.11.161. View

Lipworth L, Tarone R, McLaughlin J . The epidemiology of renal cell carcinoma. J Urol. 2006; 176(6 Pt 1):2353-8. DOI: 10.1016/j.juro.2006.07.130. View

Mellemgaard A, Niwa S, Mehl E, Engholm G, McLaughlin J, Olsen J . Risk factors for renal cell carcinoma in Denmark: role of medication and medical history. Int J Epidemiol. 1994; 23(5):923-30. DOI: 10.1093/ije/23.5.923. View

Amling C . The association between obesity and the progression of prostate and renal cell carcinoma. Urol Oncol. 2004; 22(6):478-84. DOI: 10.1016/j.urolonc.2004.10.004. View

Robles J, Rosell D, Zudaire J, Berian J . [Epidemiology of tumors of the renal parenchyma]. Rev Med Univ Navarra. 2001; 43(2):68-76. View

Matson M, Cohen E . Acquired cystic kidney disease: occurrence, prevalence, and renal cancers. Medicine (Baltimore). 1990; 69(4):217-26. DOI: 10.1097/00005792-199007000-00003. View

10.

Shapiro J, Williams M, Weiss N . Body mass index and risk of renal cell carcinoma. Epidemiology. 1999; 10(2):188-91. View

11.

Katz D, Zheng T, Holford T, Flannery J . Time trends in the incidence of renal carcinoma: analysis of Connecticut Tumor Registry data, 1935-1989. Int J Cancer. 1994; 58(1):57-63. DOI: 10.1002/ijc.2910580111. View

12.

Bannayan G, Lamm D . Renal cell tumors. Pathol Annu. 1980; 15(Pt 2):271-308. View

13.

Kanayama H, Lui W, Takahashi M, Naroda T, Kedra D, Wong F . Association of a novel constitutional translocation t(1q;3q) with familial renal cell carcinoma. J Med Genet. 2001; 38(3):165-70. PMC: 1734822. DOI: 10.1136/jmg.38.3.165. View

14.

Murai M, Oya M . Renal cell carcinoma: etiology, incidence and epidemiology. Curr Opin Urol. 2004; 14(4):229-33. DOI: 10.1097/01.mou.0000135078.04721.f5. View

15.

Stolle C, Glenn G, Zbar B, Humphrey J, Choyke P, Walther M . Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. Hum Mutat. 1998; 12(6):417-23. DOI: 10.1002/(SICI)1098-1004(1998)12:6<417::AID-HUMU8>3.0.CO;2-K. View

16.

Lindblad P, McLaughlin J, Mellemgaard A, Adami H . Risk of kidney cancer among patients using analgesics and diuretics: a population-based cohort study. Int J Cancer. 1993; 55(1):5-9. DOI: 10.1002/ijc.2910550103. View

17.

SELIKOFF I, HAMMOND E, SEIDMAN H . Mortality experience of insulation workers in the United States and Canada, 1943--1976. Ann N Y Acad Sci. 1979; 330:91-116. DOI: 10.1111/j.1749-6632.1979.tb18711.x. View

18.

Parker S, Tong T, Bolden S, Wingo P . Cancer statistics, 1997. CA Cancer J Clin. 1997; 47(1):5-27. DOI: 10.3322/canjclin.47.1.5. View

19.

Boice Jr J, Engholm G, Kleinerman R, Blettner M, Stovall M, LISCO H . Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat Res. 1988; 116(1):3-55. View

20.

Asal N, Geyer J, Risser D, Lee E, Kadamani S, Cherng N . Risk factors in renal cell carcinoma. II. Medical history, occupation, multivariate analysis, and conclusions. Cancer Detect Prev. 1988; 13(3-4):263-79. View